"Efficacy Of 1.2% Rosuvastatin Gel In The Management Of Infrabony Defects"

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2018
Study aims to evaluate clinical and radiographic effectiveness of 1.2% Rosuvastatin gel in the treatment of Infrabony defects in chronic periodontitis patients.
Epistemonikos ID: 684a53e6d7d1da3b832df17af8d012912640b750
First added on: May 21, 2024